| Cash Flow | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-09-28 |
|---|---|---|---|---|
| Revenue | - | - | 438 | 1,164 |
| Cost of revenue | - | - | 231 | 664 |
| Gross profit | - | - | 207 | 500 |
| Research and development, net | - | - | 275 | 802 |
| Sales and marketing | - | - | 31 | 90 |
| General and administrative | - | - | 18 | 52 |
| Goodwill impairment | - | - | - | 2,695 |
| Total operating expenses | - | - | 324 | 3,639 |
| Operating income (loss) | - | - | -117 | -3,139 |
| Other financial income (expense), net | - | - | - | 44 |
| Financial income (expense), net | - | - | 18 | - |
| Income (loss) before income taxes | - | - | -99 | -3,095 |
| Benefit (provision) for income taxes | - | - | 3 | -76 |
| Net income (loss) | -265 | -169 | -102 | -3,019 |
| Depreciation of property and equipment | 54 | 36 | 18 | 46 |
| Share-based compensation | 206 | 134 | 65 | 203 |
| Amortization of intangible assets | 333 | 222 | 111 | 333 |
| Goodwill impairment | - | - | - | 2,695 |
| Exchange rate differences on cash and cash equivalents | 8 | 8 | 2 | -2 |
| Deferred income taxes | 16 | 11 | 6 | 98 |
| (gains) losses on equity and debt investments, net | - | 1 | - | - |
| Other | -5 | -4 | - | -1 |
| Decrease (increase) in trade accounts receivable | -11 | 5 | 5 | -113 |
| Decrease (increase) in other current assets | -15 | -12 | -15 | -7 |
| Decrease (increase) in inventories | -97 | -90 | -51 | 66 |
| Increase (decrease) in accounts payable, accrued expenses and related party payable | 22 | 4 | -36 | -55 |
| Increase (decrease) in employee-related accrued expenses and long-term benefits | 32 | 17 | - | 24 |
| Increase (decrease) in other current liabilities | -1 | -6 | -5 | 10 |
| Decrease (increase) in other long-term assets | 3 | 2 | -3 | 5 |
| Increase (decrease) in other long-term liabilities | 7 | 5 | 2 | 5 |
| Net cash provided by operating activities | 489 | 322 | 109 | 196 |
| Purchase of property and equipment | 52 | 28 | 14 | 68 |
| Purchases of debt and equity investments | 79 | 44 | 25 | 32 |
| Maturities and sales of debt and equity investments | 67 | 33 | 14 | 2 |
| Net cash used in investing activities | -64 | -39 | -25 | -98 |
| Share-based compensation recharge | 2 | - | -3 | 16 |
| Repurchase of common stock from parent | 100 | - | - | - |
| Net cash used in financing activities | -102 | - | 3 | -16 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 8 | 8 | 2 | -2 |
| Increase in cash, cash equivalents and restricted cash | 331 | 291 | 89 | 80 |
| Cash and cash equivalents at beginning of period | 1,438 | 1,438 | 1,438 | 1,226 |
| Cash and cash equivalents at end of period | 1,769 | 1,729 | 1,527 | 1,306 |
Mobileye Global Inc. (MBLY)
Mobileye Global Inc. (MBLY)